Connection

JIANMING XU to Antineoplastic Agents, Hormonal

This is a "connection" page, showing publications JIANMING XU has written about Antineoplastic Agents, Hormonal.
Connection Strength

0.186
  1. A SNP in steroid receptor coactivator-1 disrupts a GSK3? phosphorylation site and is associated with altered tamoxifen response in bone. Mol Endocrinol. 2012 Feb; 26(2):220-7.
    View in: PubMed
    Score: 0.068
  2. Global characterization of the SRC-1 transcriptome identifies ADAM22 as an ER-independent mediator of endocrine-resistant breast cancer. Cancer Res. 2012 Jan 01; 72(1):220-9.
    View in: PubMed
    Score: 0.068
  3. Genetic screening reveals an essential role of p27kip1 in restriction of breast cancer progression. Cancer Res. 2007 Sep 01; 67(17):8032-42.
    View in: PubMed
    Score: 0.051
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.